earnings
confidence high
sentiment positive
materiality 0.75
Rapid Micro Biosystems Q3 revenue $7.8M (+3% YoY); raises FY guidance after record multi-system order
RAPID MICRO BIOSYSTEMS, INC.
2025-Q3 EPS
reported -$0.78
vs consensus -$0.25
▼ miss
(-212.1%)
- Q3 2025 revenue $7.8M (+3% YoY); recurring revenue up 32% to $4.8M on record consumables.
- Net loss $11.5M ($0.26 loss per share), flat YoY; gross margin improved to 9% from 8%.
- Receives largest multi-system order in company history from existing Top 20 global biopharma customer.
- Raises FY2025 revenue guidance to at least $33.0M, assumes at least 27 Growth Direct placements.
- Cash and equivalents $42M as of Sept 30, 2025.
item 2.02item 9.01